BioNTech Results Presentation Deck

BioNTech: A Global Immunotherapy Powerhouse Deep Immunology Expertise Fully Integrated 7 Broad Suite of Novel Technologies Automation & Digitalization Specialized Manufacturing Commercial Capabilities Global Team of 2,800+ ✓ ✓ A Diverse Pipeline of 20+ Candidates ● *as of Nov. 2, 2021: includes doses shipped by collaboration partner Pfizer Next-Generation Immunotherapies & Vaccines Oncology, Infectious Diseases and Beyond Delivered >2 bn doses of COVID-19 vaccine* Initiated 3 randomized Phase 2 clinical trials Initiated 5 first-in-human trials Potential to Launch Multiple Products in the Next 5 Years BIONTECH

View entire presentation